Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria

• Published in: Cochrane database of systematic reviews 2011-04, Vol.2011 (4), p.CD004615-CD004615
• Main Authors: Okoromah, Christy An, Afolabi, Bosede B, Wall, Emma Cb
• Format: Article
• Language: English
• Subjects: Adult; Antimalarials - therapeutic use; Blood disorders; Child; Child health; Diuretics, Osmotic - therapeutic use; Humans; Infectious disease; Malaria; Malaria, Cerebral - drug therapy; Mannitol - therapeutic use; Quinine - therapeutic use; Randomized Controlled Trials as Topic; Uganda; Urea - therapeutic use
• ISSN: 1469-493X
• DOI: 10.1002/14651858.CD004615.pub3

Cerebral oedema occurs with cerebral malaria, and some clinicians think osmotic diuretics, such as mannitol or urea, may improve outcomes. To compare mannitol or urea to placebo or no diuretic for treating children or adults with cerebral malaria. We searched the Cochrane Infectious Diseases Group Specialized Register (Issue 4, 2010), CENTRAL (The Cochrane Library Issue 12, 2010), MEDLINE (1966 to November 2010), EMBASE (1974 to November 2010), LILACS (1982 to November 2010), and the reference lists of articles. We contacted relevant organizations and researchers. Randomized or quasi-randomized controlled trials comparing mannitol or urea to placebo or no treatment in children and adults with cerebral malaria. Primary outcomes were death, life-threatenining sequelae and major neurological sequelae at six months. Two authors applied the inclusion criteria, assessed risk of bias, and extracted data independently. One trial met the inclusion criteria, comparing mannitol 20% to saline placebo in 156 Ugandan children. Allocation was concealed. No difference in mortality, time to regain consciousness, or neurological sequelae were detected. There are insufficient data to know what the effects of osmotic diuretics are in children with cerebral malaria. Larger, multicentre trials are needed.